5th Annual Drug Development Congress 2013
10 Jun 2013 - 11 Jun 2013 - Geneva, Switzerland
Oxford Global Conferences are proud to present the 5th Annual Drug Development Congress, taking place on the 10th & 11th June in Geneva.
It is estimated that the average drug costs the world’s leading
pharmaceutical companies at least $4 billion to develop. Amid fears that
the current large pharma model is not working, this event focuses on
attempts to break down discovery and development boundaries and promote
knowledge share between therapy areas.
On Day One, our expert speakers will discuss key areas for
improvement in drug development, including translational modelling,
safety & efficacy testing and reducing timelines for
biopharmaceutical pipelines. Topics will include assay development,
pharmacokinetic challenges and updates on the latest NGS applications.
Day Two will cover the latest methods to improve decision making in
drug development; from advances in biomarker technology, to the
integration of safety studies earlier in the pipeline. Our expert
speakers will also present collaboration case studies, discussing both
external and internal attempts to harness complimentary skills and
reduce late stage failure.
To maintain the extensive networking opportunities enjoyed by last
year’s delegates, the development congress will once again be co-located
with our discovery summit. The 14th Annual Drug Discovery Leaders’ Summit
has a long-held association with the leaders in medicinal chemistry and
drug design. This year’s event will focus on innovation. Experts will
discuss how new developments in screening, assay development,
structure-activity analysis and anti-target effect prediction will
influence the success of discovery portfolios.